Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

Despite the glorious performance of the pharmaceutical sector, India faced a huge setback because of the recent incident when ...

The phase 3 trial showed biosimilar CT-P42 (Celltrion) is therapeutically equivalent to reference aflibercept in improving ...

Pune-based startup Atreya Innovations has developed an AI-powered pulse diagnostic tool for Ayurveda practitioners, 'Nadi ...

Pune-based startup Atreya Innovations said it has developed an AI-based pulse diagnostic tool for Ayurveda practitioners that can monitor patients’ health on 22 parameters and generate report in 10 ...

Pune: Nadi Tarangini, the country's first ayurvedic diagnostic tool to receive approval from Central Drugs Standard Control Organization (CDSCO), is e.

In 2023-24, around 2,988 drug samples were declared ‘not of standard quality’ while 282 drug samples were found to be ...

Nadi Tarangini, an indigenously developed pulse diagnostic tool, has become India’s first ayurvedic medical device to receive ...

CDSCO brings clinical trial site addition and change of PI applications to online mode: Gireesh Babu, New Delhi Thursday, January 2, 2025, 08:00 Hrs [IST] The Central Drugs Standa ...

India's new drug approval process waiver raises concerns about patient safety, research, and healthcare implications, experts ...

a drug-resistant bacteria, is a major concern for doctors Enmetazobactam, developed by Chennai-based Orchid Pharma, is the first antimicrobial invented in India to be approved by the US Food and ...

Now, even the US’ Food and Drug Administration (FDA ... or masala tea. The Indian Tea Association, country’s oldest group of tea producers hailed FDA’s decision and stated, “The Indian ...